Leptin increase is associated with markers of the hemostatic system in obese healthy women (Q38347821)

2 September 2017

Leptin increase is associated with markers of the hemostatic system in obese healthy women (English)

1 reference

2 September 2017

0 references

7

Basili S

1 reference

2 September 2017

Guagnano MT

1

1 reference

2 September 2017

Romano M

2

1 reference

2 September 2017

Falco A

3

1 reference

2 September 2017

Nutini M

4

1 reference

2 September 2017

Marinopiccoli M

5

1 reference

2 September 2017

Manigrasso MR

6

1 reference

2 September 2017

Davì G

8

1 reference

2 September 2017

1 November 2003

1 reference

Journal of Thrombosis and Haemostasis

2 September 2017

1 reference

2 September 2017

1

1 reference

2 September 2017

2330-2334

1 reference

2 September 2017

11

1 reference

Platelet activation in obese women: role of inflammation and oxidant stress

2 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Biological action of leptin as an angiogenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Effect of degree of weight loss on health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Partial leptin deficiency and human adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00445.X

10.1046/J.1538-7836.2003.00445.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference